239 related articles for article (PubMed ID: 1991803)
1. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
2. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
Takami H; Ito K
Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening.
Schifter S
Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082
[TBL] [Abstract][Full Text] [Related]
6. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma calcitonin gene-related peptide and the symptoms associated with medullary thyroid cancer.
Rubinstein C; Fletcher DR; Shulkes A; Hardy KJ
Aust N Z J Surg; 1992 Nov; 62(11):892-6. PubMed ID: 20169709
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
10. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of plasma calcitonin gene-related peptide (CGRP) level in patients with thyroid disease].
Takami H; Shikata J; Ozaki O; Mimura T; Ito K
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):401-6. PubMed ID: 2359396
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.
Grauer A; Raue F; Ziegler R
Exp Clin Endocrinol Diabetes; 1998; 106(4):353-9. PubMed ID: 9792470
[TBL] [Abstract][Full Text] [Related]
13. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
14. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin gene-related peptide: possible tumor marker for medullary thyroid cancer.
Poston GJ; Seitz PK; Townsend CM; Alexander RW; Rajaraman S; Cooper CW; Thompson JC
Surgery; 1987 Dec; 102(6):1049-54. PubMed ID: 3500524
[TBL] [Abstract][Full Text] [Related]
16. Role of cytosolic free calcium concentration in the secretion of calcitonin gene-related peptide and calcitonin from medullary thyroid carcinoma cells.
Haller-Brem S; Muff R; Petermann JB; Born W; Roos BA; Fischer JA
Endocrinology; 1987 Oct; 121(4):1272-7. PubMed ID: 3498624
[TBL] [Abstract][Full Text] [Related]
17. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
[TBL] [Abstract][Full Text] [Related]
19. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
[TBL] [Abstract][Full Text] [Related]
20. Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests.
Camacho CP; Lindsey SC; Melo MC; Yang JH; Germano-Neto F; Valente Fde O; Lima TR; Biscolla RP; Vieira JG; Cerutti JM; Dias-da-Silva MR; Maciel RM
Thyroid; 2013 Mar; 23(3):308-16. PubMed ID: 23259706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
